Research Use Only - Not for human consumption. 18+ only.
CGrade CPrimarily animal or in-vitro studies; limited human dataResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use onlyGrowth Hormone SecretagoguesSubcutaneous

GHRP-5

Experimental growth hormone releasing peptide (GHRP) with limited clinical data. Research compound used to investigate growth hormone secretion pathways and metabolic effects. Not approved for human use.

Beginner Basics

Plain-English guide to GHRP-5

What it does

GHRP-5 signals your body to release more growth hormone, a natural substance involved in muscle growth and metabolism. Researchers study it to understand how growth hormone pathways work and its effects on body composition.

Typical dose

Researchers typically use 100-200 micrograms (mcg) injected under the skin once to three times daily, starting at the lower end to see how your body responds.

When to inject

Best used before meals or before bed, as timing around food may affect how well it works to trigger growth hormone release.

Storage

Keep the dry powder in a cool, dark place until mixed. Once mixed with liquid, store in the refrigerator and use within the timeframe specified by your supplier.

First-timer tip

Start with the lowest dose (100 mcg) for a few days to see how your body responds before increasing, and keep your injection timing consistent each day for best results.

Research Status

CGrade CPrimarily animal or in-vitro studies; limited human dataResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only

Early Research

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Stimulates growth hormone release
May enhance muscle protein synthesis
Supports metabolic rate
May improve body composition
Potential appetite stimulation effects

Side Effects

Increased appetite
CommonMild

Ghrelin receptor agonism stimulates appetite. Typically resolves within hours post-injection. Manage by planning meals in advance or eating before injection if appetite stimulation is undesirable.

Injection site reactions (redness, itching, mild swelling)
CommonMild

Local inflammatory response at injection site. Usually resolves within 1-2 hours. Minimize by rotating sites, using proper injection technique, and allowing the solution to reach room temperature before injection.

Flushing or facial warmth
UncommonMild

Transient vasodilation associated with GH release. Typically occurs 15-30 minutes post-injection and resolves within 30-60 minutes.

Headache
UncommonMild

May occur in response to rapid GH elevation. Usually mild and self-resolving. Ensure adequate hydration.

Dizziness or lightheadedness
UncommonMild

May occur with rapid GH secretion, particularly if injected while standing. Sit or lie down for 5-10 minutes post-injection if this occurs.

Tachycardia (elevated heart rate)
UncommonMild

Transient increase in heart rate associated with GH release. Usually resolves within 30-60 minutes. Monitor if you have cardiovascular concerns.

Desensitization (reduced GH response over time)
CommonModerate

Repeated GHRP dosing within 2-4 hours causes receptor desensitization and blunted GH response. Spacing doses 4-6+ hours apart or using intermittent dosing protocols (e.g., 5 days on, 2 days off) may help maintain responsiveness.

Lipodystrophy (localized fat loss or thickening)
UncommonModerate

Chronic repeated injections at the same site can cause localized fat atrophy or hypertrophy. Prevent by strictly rotating injection sites with each dose and spacing injections at least 1 inch apart.

Cortisol elevation
UncommonModerate

GHRPs may transiently elevate cortisol. Individuals with adrenal insufficiency or cortisol sensitivity should exercise caution. Not typically clinically significant with short-term use.

Prolactin elevation
RareMild

Some GHRPs may cause mild transient prolactin elevation. Clinically significant elevation is rare. Monitor if you have prolactin-sensitive conditions.

Dosing Reference

ParameterValue
Dose range100-200 mcg
Frequency, timing and route - members only

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2-8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

GHRP-5 is a synthetic growth hormone releasing peptide that acts as a ghrelin receptor agonist (GHS-R1a), stimulating the release of growth hormone from the anterior pituitary gland. It works synergistically with endogenous growth hormone-releasing hormone (GHRH) to enhance GH secretion. The peptide mimics the action of ghrelin, a natural orexigenic hormone, triggering GH pulses independent of somatostatin inhibition.

Pathways and mechanism detail available to members

Track your GHRP-5 research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. GHRP-5 is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.